RECRUITING

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Talk to us

Conditions

Alzheimers DiseaseEarly Alzheimers DiseaseMild Cognitive ImpairmentMild Dementia

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Official Title

Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies as Assessed by Biomarker Status and Cognition

Quick Facts

Study Start:2025-07-02
Study Completion:2035-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07177352

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * Dependency in basic activities of daily living (bADLs) due to cognitive impairment
  2. * Visual or auditory impairment that would prevent them from performing the cognitive assessments (eyeglasses and hearing aids are permitted)
  3. * Any self-reported evidence or known diagnosis of a neurological or neurodegenerative condition that may lead to cognitive impairment other than AD
  4. * History of severe, clinically significant central nervous system trauma
  5. * Any serious medical condition that precludes a participant's safe participation and completion of a clinical study

Contacts and Locations

Study Contact

Reference Study ID Number: WP45722 https://forpatients.roche.com/
CONTACT
888-662-6728 (U.S. and Canada)
global-roche-genentech-trials@gene.com

Principal Investigator

Clinical Trials
STUDY_DIRECTOR
Hoffmann-La Roche

Study Locations (Sites)

Sun Valley Research Center, Inc.
Imperial, California, 92251
United States
Inglewood Clinicals
Inglewood, California, 90301
United States
Irvine Center for Clinical Research
Irvine, California, 92614
United States
Healthy Brain Clinic
Long Beach, California, 90804
United States
Oakland Clinical
Oakland, California, 94609
United States
Riverside Clinical
Riverside, California, 92506
United States
Syrentis Clinical Research
Santa Ana, California, 92705
United States
Cenexel California Neuroscience Research, LLC
Sherman Oaks, California, 91403
United States
JEM Research LLC
Atlantis, Florida, 33462
United States
K2 Medical Research-Winter Garden
Clermont, Florida, 34711
United States
K2 Medical Research - The Villages
Lady Lake, Florida, 32159
United States
K2 Medical Research, LLC
Maitland, Florida, 32751
United States
Visionary Investigators Network- Neurology Aventura
Miami, Florida, 33133
United States
Renstar Medical Research
Ocala, Florida, 34470
United States
Charter Research - Winter Park/Orlando
Orlando, Florida, 32803
United States
Conquest Research - Lake Nona
Orlando, Florida, 32832
United States
Alzheimer's Research and Treatment Center
Stuart, Florida, 34997
United States
Axiom Brain Health LLC
Tampa, Florida, 34654
United States
Charter Research - Lady Lake/The Villages
The Villages, Florida, 32162
United States
Alzheimer?s Research and Treatment Center
Wellington, Florida, 33414
United States
Conquest Research, LLC
Winter Park, Florida, 32789
United States
Accel Research Sites-NeuroStudies
Decatur, Georgia, 30030
United States
CenExel iResearch, LLC
Decatur, Georgia, 30030
United States
Center for Advanced Research & Education
Gainesville, Georgia, 30501
United States
Hawaii Pacific Neuroscience
Honolulu, Hawaii, 96817
United States
RE:Cognition (Chicago)
Chicago, Illinois, 60611
United States
Great Lakes Clinical Trials Chicago d/b/a Flourish Research Andersonville
Chicago, Illinois, 60640
United States
Adams Clinical Boston
Boston, Massachusetts, 02116
United States
Boston Center for Memory
Newton, Massachusetts, 02459
United States
Adams Clinical Watertown
Watertown, Massachusetts, 02472
United States
Quest Research Institute
Farmington Hills, Michigan, 48334
United States
Washington University School of MedicineClinical Translational Research Unit
St Louis, Missouri, 63110
United States
The Cognitive and Research Center of New Jersey
Ridgewood, New Jersey, 07450
United States
The Cognitive and Research Center of New Jersey
Springfield, New Jersey, 07081
United States
Basil Clinical
Laurelton, New York, 11413-2016
United States
Adams Clinical Harlem
New York, New York, 10029
United States
Adams Clinical Bronx
The Bronx, New York, 10461
United States
Triad Clinical Trials
Greensboro, North Carolina, 27410
United States
Summit Research Network Inc.
Portland, Oregon, 97210
United States
Flourish Research ? Philadelphia
Plymouth Meeting, Pennsylvania, 19462
United States
Palmetto Clinical Trials
Summerville, South Carolina, 29485
United States
Genesis Neuroscience Clinic
Knoxville, Tennessee, 37909
United States
K2 Medical Research - Nashville
Nashville, Tennessee, 37204
United States
South Texas Research Institute - Brownsville
Brownsville, Texas, 78520
United States
Kerwin Medical Center
Dallas, Texas, 75216
United States
Kerwin Research Center, LLC
Dallas, Texas, 75231
United States
South Texas Research Institute - Edinburg
Edinburg, Texas, 78539
United States
Re:Cognition Health - Fort Worth
Fort Worth, Texas, 76104
United States
Re:Cognition Health - Houston
Houston, Texas, 77030
United States
Mt.Olympus Medical Research
Katy, Texas, 77450
United States
Sana Research, LLC
Arlington, Virginia, 22205
United States
Re:Cognition Health
Fairfax, Virginia, 22031
United States
National Clinical Research Inc.-Richmond
Richmond, Virginia, 23294
United States

Collaborators and Investigators

Sponsor: Hoffmann-La Roche

  • Clinical Trials, STUDY_DIRECTOR, Hoffmann-La Roche

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-07-02
Study Completion Date2035-07-31

Study Record Updates

Study Start Date2025-07-02
Study Completion Date2035-07-31

Terms related to this study

Keywords Provided by Researchers

  • Early Alzheimers Disease
  • Mild Cognitive Impairment
  • Mild Dementia

Additional Relevant MeSH Terms

  • Alzheimers Disease